{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:18:31Z","timestamp":1791893911739,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011821","name":"Ministry of Education \u2013 Kingdom of Saudi Arabi","doi-asserted-by":"publisher","award":["IFKSURG-1175"],"award-info":[{"award-number":["IFKSURG-1175"]}],"id":[{"id":"10.13039\/501100011821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejmech.2023.115538","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T15:18:17Z","timestamp":1685632697000},"page":"115538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer"],"prefix":"10.1016","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6996-4017","authenticated-orcid":false,"given":"Wagdy M.","family":"Eldehna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslam E.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada H.","family":"Al-Ansary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiy Y.","family":"Jaballah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara T.","family":"Al-Rashood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizah A.","family":"Binjubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzy A.","family":"Elbarbry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikrettin","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115538_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejmech.2016.12.035","article-title":"Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors","volume":"127","author":"Peng","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104510","article-title":"Design and synthesis of novel quinoline\/chalcone\/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases","volume":"106","author":"Mohassab","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/14756366.2021.2015344","article-title":"2-Arylquinolines as novel anticancer agents with dual EGFR\/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights","volume":"37","author":"Elbadawi","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib4","first-page":"1","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA","volume":"0","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2023.115538_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/1871520618666171129213838","article-title":"Design, synthesis and cytotoxicity evaluation of new 3, 5-disubstituted-2-thioxoimidazolidinones","volume":"18","author":"Abdellatif","year":"2018","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131574","article-title":"Design, synthesis and biological evaluation of novel thiohydantoin derivatives as antiproliferative agents: a combined experimental and theoretical assessments","volume":"1249","author":"Elbadawi","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2023.115538_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127459","article-title":"Design, synthesis and biological evaluation of ring-fused pyrazoloamino pyridine\/pyrimidine derivatives as potential FAK inhibitors","volume":"30","author":"Xie","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115538_bib8","first-page":"58","article-title":"Design, synthesis, molecular docking and cytotoxicity evaluation of some novel 5-arylidene-3-(substituted phenyl)-2-(p-tolylamino)-4-imidazolones","volume":"7","author":"Khodair","year":"2017","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2023.115538_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12935-020-01719-5","article-title":"The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment","volume":"21","author":"Emami Nejad","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2023.115538_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2023.115538_bib11","series-title":"The Role of Hypoxia in Cancer Progression, Angiogenesis, Metastasis, and Resistance to Therapy","author":"Muz","year":"2015"},{"key":"10.1016\/j.ejmech.2023.115538_bib12","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2023.115538_bib13","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bmc.2012.09.047","article-title":"An\u03b1-carbonic anhydrase from the thermophilic bacterium Sulphurihydrogenibium azorense is the fastest enzyme known for the CO2 hydration reaction","volume":"21","author":"Luca","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112923","article-title":"Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors","volume":"209","author":"Kumar","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib15","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2023.115538_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115538_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejmech.2018.10.068","article-title":"Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents","volume":"162","author":"Eldehna","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14756366.2021.2024528","article-title":"Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms","volume":"37","author":"Eldehna","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114190","article-title":"Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach","volume":"232","author":"Tawfik","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib20","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115538_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008-2013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2023.115538_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2019.06.081","article-title":"Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic\/phobic tails for targeting the middle region of human carbonic anhydrases active site: selective inhibitors of hCA IX","volume":"179","author":"Allam","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113283","article-title":"Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors","volume":"216","author":"Shaldam","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113360","article-title":"Identification of N-phenyl-2-(phenylsulfonyl) acetamides\/propanamides as new SLC-0111 analogues : synthesis and evaluation of the carbonic anhydrase inhibitory activities","volume":"218","author":"Elbadawi","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114004","article-title":"Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine\u2013Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors","volume":"228","author":"Abdel-Mohsen","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2023.115538_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105920","article-title":"A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors","volume":"126","author":"Kumar","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114008","article-title":"Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors","volume":"228","author":"Elimam","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113800","article-title":"Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: design, synthesis and biological evaluation","volume":"225","author":"Elimam","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115538_bib30","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1080\/14756366.2022.2124409","article-title":"Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII","volume":"37","author":"Al-Warhi","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib31","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib32","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bioorg.2019.04.002","article-title":"Novel synthesized SLC-0111 thiazole and thiadiazole analogues: determination of their carbonic anhydrase inhibitory activity and molecular modeling studies","volume":"87","author":"Abo-Ashour","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib33","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bmc.2019.03.001","article-title":"Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors","volume":"27","author":"Lolak","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bioorg.2018.11.014","article-title":"SLC-0111 enaminone analogs, 3\/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX","volume":"83","author":"Eldehna","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib35","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase: I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2023.115538_bib37","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.2147\/OTT.S177605","article-title":"Carbonic anhydrase IX enhances tumor cell proliferation and tumor progression in osteosarcoma","volume":"11","author":"Okuno","year":"2018","journal-title":"OncoTargets Ther."},{"issue":"11","key":"10.1016\/j.ejmech.2023.115538_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207417","article-title":"Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: disconnect between activity and growth inhibition","volume":"13","author":"Mboge","year":"2018","journal-title":"PLoS One"},{"issue":"46","key":"10.1016\/j.ejmech.2023.115538_bib39","doi-asserted-by":"crossref","first-page":"43221","DOI":"10.1074\/jbc.M104446200","article-title":"Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides","volume":"276","author":"Xu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib40","first-page":"1","article-title":"Measurement of apoptosis by DNA fragmentation","volume":"282","author":"Matassov","year":"2004","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115538_bib41","first-page":"165","article-title":"Caspase control: protagonists of cancer cell apoptosis","volume":"34","author":"Fiandalo","year":"2012","journal-title":"Exp. Oncol."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115538_bib42","first-page":"4969","article-title":"Comparison of the biological characteristics of human mesenchymal stem cells derived from exfoliated deciduous teeth, bone marrow, gingival tissue, and umbilical cord","volume":"18","author":"Li","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2023.115538_bib43","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1021\/acs.jmedchem.6b01389","article-title":"Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations","volume":"59","author":"Nocentini","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib44","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115538_bib45","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/14756366.2018.1547286","article-title":"Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents","volume":"34","author":"Eldehna","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115538_bib46","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/molecules23061459","article-title":"Pyridine-ureas as potential anticancer agents: synthesis and in vitro biological evaluation","volume":"23","author":"El-Naggar","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115538_bib47","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1021\/acs.jmedchem.9b02090","volume":"63","author":"Fares","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115180","article-title":"\"4-(5-Amino-pyrazol-1-yl) benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: design, synthesis, and biological assessments","volume":"250","author":"Ragab","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111843","article-title":"\"Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine\/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors","volume":"185","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2191163","article-title":"\"Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors","volume":"38","author":"Elsayed","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115538_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113261","article-title":"Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity","volume":"215","author":"Elbadawi","year":"2021","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423005044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423005044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:53:49Z","timestamp":1759330429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423005044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":51,"alternative-id":["S0223523423005044"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115538","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115538"}}